NASDAQ · PTN
Palatin Technologies, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PTN: Nov 13, 2026
Palatin Technologies, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $4.26.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · RTTNews · Quiver Quantitative- The Motley Fool · Sep 29, 3:14 AM EDTPalatin (PTN) Q4 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Feb 2, 6:12 AM ESTThis High-Flying Growth Stock Is Hiding in Plain SightMany investors aren't familiar with Rhythm Pharmaceuticals because of its small size and focus on rare diseases.
- RTTNews · Sep 22, 9:45 AM EDTPalatin Achieves Milestone Payment Of $6.5 Mln Under Boehringer Ingelheim Collaboration(RTTNews) – Palatin Technologies, Inc. (PTNTD.PK), Monday announced that the company has reached a research milestone, worth 5.5 million euros, equivalent to $6.5 million, under its collaboration with Boehringer Ingelheim.
- Quiver Quantitative · Jun 17, 4:47 PM EDTInsider Purchase: Executive VP and CFO/COO of $PTN Buys 1,500 SharesSTEPHEN T WILLS, the Executive VP and CFO/COO of $PTN, bought 1,500 shares of the company on 06-13-2025 for an estimated $225,000,000. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by appro
- RTTNews · May 14, 8:12 AM EDTPalatin Technologies Q1 Net Loss Narrows On Lower Expenses(RTTNews) – Palatin Technologies, Inc. (PTNT.PK), a biopharmaceutical company, on Wednesday reported narrower net loss in its first quarter with sharply lower operating expenses.
- RTTNews · May 9, 5:42 PM EDTPalatin Unveils Promising Preclinical Data For Diabetic Retinopathy Treatments At ARVO 2025(RTTNews) – Palatin Technologies, Inc. (PTNT), a biopharmaceutical company advancing melanocortin-based therapies, shared new preclinical findings at the 2025 ARVO Annual Meeting.
- RTTNews · May 7, 1:50 PM EDTPalatin Prices $11.5 Mln Public Offering(RTTNews) – Palatin Technologies, Inc. (PTN), a biopharmaceutical firm focused on melanocortin-based treatments, has priced a public offering totaling approximately $11.5 million.
- RTTNews · May 7, 1:49 PM EDTPalatin Expects $11.5 Mln Offering To Aid NYSE Compliance And Fuel Obesity Drug Development(RTTNews) – Palatin Technologies, Inc. (PTN) Wednesday announced that it anticipates closing its previously disclosed public offering on May 8, 2025.
- RTTNews · May 5, 9:01 AM EDTPalatin Technologies Announces Encouraging Pre-Clinical Data Of PL9588 For Glaucoma Treatment(RTTNews) – Palatin Technologies, Inc. (PTN), Monday announced new pre-clinical data for PL9588, a novel melanocortin receptor agonist, for the treatment of for glaucoma, a progressive, often pressure-related disease.
- RTTNews · Apr 29, 8:45 AM EDTPalatin Reports Positive Results From Responder Analyses Of Phase 3 MELODY-1 Study In DED(RTTNews) – Palatin Technologies, Inc. (PTN), a biopharmaceutical company, Tuesday reported updated results from responder analyses of its pivotal Phase 3 MELODY-1 study evaluating the safety and efficacy of PL9643 versus placebo in the treatment of dry eye disease (DED).
- RTTNews · Apr 17, 8:44 AM EDTPalatin's Phase 2 Obesity Study Shows Encouraging Appetite Suppression Data, Stock Up In Pre-Market(RTTNews) – Palatin Technologies, Inc. (PTN), Thursday announced results from its BMT-801 Phase 2 obesity study, which evaluated the co-administration of melanocortin 4 receptor or MC4R agonist bremelanotide plus glucagon like peptide-1/gastric inhibitory polypeptide or GLP-1/GIP
- RTTNews · Apr 14, 4:31 PM EDTPalatin Appeals NYSE Delisting, Pursues Financing And Partnerships To Regain Compliance(RTTNews) – Palatin Technologies, Inc. (PTN) Monday announced that it has appealed the NYSE American's decision to delist its stock after failing to meet stockholders' equity requirements by the April 10, 2025 deadline.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Palatin Technologies, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.